Health
ColCORONA: Colchicine Reduces Complications in Outpatient COVID-19 – Medscape
The primary endpoint was not significant in the overall population, but in those with PCR-confirmed COVID, treatment reduced hospitalization, need for ventilation,…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The oral, anti-inflammatory drug colchicine can prevent complications and hospitalizations in nonhospitalized patients newly diagnosed with COVID-19, according to a press release from the ColCORONA trial investigators.
After 1 month of therapy, there was a 21% risk reduction in the primary composite endpoint of death or hospitalizations that missed statistical significance, compared with placebo…
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General10 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business14 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Business22 hours agoEconomic roundtable or maturity test?